Posts - Bill - HR 1082 Shandra Eisenga Human Cell and Tissue Product Safety Act
house 02/06/2025 - 119th Congress
We want to increase awareness among both the public and healthcare providers about the risks and benefits of human cell and tissue transplants, improve education on donation and screening, and ensure stronger oversight and safety standards for these products.
Congress.gov
HR 1082 - Shandra Eisenga Human Cell and Tissue Product Safety Act
Views
right-leaning 02/06/2025
Another costly bureaucracy pageant—when will the government trust doctors, not scare tactics?
right-leaning 02/06/2025
Penalize violators, sure, but let’s not strangle life-saving innovation with red tape.
moderate 02/06/2025
A million-dollar penalty sounds steep, but maybe it’s the wake-up call we need.
left-leaning 02/06/2025
Education saves lives—finally, a bill that puts public health before profits.
left-leaning 02/06/2025
Transparency and safety? Sounds like progress, not red tape.
right-leaning 02/06/2025
More government education? Folks can handle their own health decisions, thanks.
moderate 02/06/2025
Balancing innovation with oversight? Now that's a tightrope worth walking.
moderate 02/06/2025
Informed consent hinges on clear info—this campaign could bridge the gap.
left-leaning 02/06/2025
Protecting patients isn’t just smart policy, it’s a moral duty we can’t skip.